SpeeDx
PrivateLast Round
Series C
Feb 28, 2023
Total Funding Raised
$52.01M
Company Overview
SpeeDx is a molecular diagnostics company that develops innovative multiplex systems for clinical diagnostics utilizing real-time polymerase chain reaction technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpeeDx Comparables
Compare SpeeDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ChromaCode | 80% | |
| Seegene Inc. | 79% | |
| R-Biopharm AG | 78% |
SpeeDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 28, 2023 | ||||
| Grant | Jul 16, 2021 | ||||
| Grant | May 10, 2021 | ||||
| Grant | Sep 3, 2020 | ||||
| Series B | Feb 11, 2020 | ||||
Series A | Aug 5, 2019 |
Key People
Founding team and executive leadership
SpeeDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Platinum Asset Management | Series C |
| NSW Medical Device Fund | Grant |
| Northpond Ventures | Series C, Series A, Series B |
| Tattarang | Series C |
| Northpond Ventures | Series C, Series A, Series B |
| Australian Government Department of Industry, Science and Resources | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 28, 2023
$17M round led by Platinum Asset Management and Tattarang.
- May 10, 2021
$1.8M grant awarded by CARB-X
SpeeDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SpeeDx's valuation, stock price, and market status.
Is SpeeDx a public or private company?
SpeeDx is a private company.
What is the current stock price of SpeeDx?
SpeeDx is a private company, so its shares have no public market price. Caplight tracks SpeeDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpeeDx worth (valuation)?
Valuation information for SpeeDx is not publicly available.
Can I buy SpeeDx stock?
SpeeDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpeeDx's last funding round?
SpeeDx's most recent funding round was Series C on February 28, 2023.
Who are the main investors in SpeeDx?
Key investors in SpeeDx include Platinum Asset Management, Northpond Ventures, Tattarang, Northpond Ventures, Tenmile.
Will SpeeDx IPO soon?
No public IPO plans have been announced for SpeeDx.
How can I track SpeeDx secondary market activity?
Caplight tracks bids, offers, and trades in SpeeDx's shares on secondary markets.